International Accreditation System for Interventional Oncology Services
Istituto Nazionale dei Tumori
IASIOS FACILITY PROFILE

Istituto Nazionale dei Tumori

Milan · Italy · Europe
Accredited Centre The Accredited Centre seal is a recognition of adherence to the CIRSE Standards of QA in IO, and represents a high standard of IO care provided by a facility.
IASIOS Accredited Centre

About the facility

Istituto Nazionale dei Tumori (INT) is a public comprehensive cancer centre in Milan, Italy, specialising in cancer care, clinical research and medical education. Its dedicated Interventional Oncology Unit provides minimally invasive, image-guided treatments for primary and metastatic tumours, alongside interventions for cancer-related complications.

Cancer types and organs treated

  • Primary liver cancer, including hepatocellular carcinoma
  • Liver metastases
  • Kidney tumours
  • Selected soft tissue tumours, including desmoid tumours
  • Primary and metastatic bone tumours

Interventional oncology procedures

  • Radiofrequency ablation (RFA)
  • Microwave ablation (MWA)
  • Cryoablation, particularly for kidney and selected soft tissue tumours
  • Transarterial chemoembolisation (TACE)
  • Transarterial radioembolisation (TARE/SIRT)
  • Percutaneous tumour ablation and cementoplasty for bone lesions
  • Image-guided biopsies
  • Biliary drainage, vascular stenting and tumour-related embolisation

Clinical approach

Led by Dr. Rodolfo Lanocita, the Interventional Oncology Unit combines local tumour ablation and catheter-based therapies with comprehensive multidisciplinary cancer care. The team follows regularly reviewed internal quality protocols and collaborates with other specialist departments to deliver individualised treatments. The unit is also active in clinical research and specialist education, with a focus on patient safety, minimally invasive care and continuous quality improvement.

Visit facility website →